![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis |
Byung-Ho Yoon, Youjin Lee, Hyun Jin Oh, Sung Han Kim, Young-Kyun Lee |
jbm. 2019;26(1):51-60. Published online February 28, 2019 DOI: https://doi.org/10.11005/jbm.2019.26.1.51 |
Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis Considerations in Thyrotropin-Stimulating Hormone Suppression in Individuals with Differentiated Thyroid Cancer Surveillance of Treated Thyroid Cancer Patients and Thyroid Hormone Replacement and Suppression Thyroid stimulating hormone suppression time on cardiac function of patients with differentiated thyroid carcinoma Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score Risk of Osteoporotic Fractures after Thyroid-stimulating Hormone Suppression Therapy in Patients with Thyroid Cancer Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer Influence of Clinical Characteristics and Parameters Associated with Thyroid Hormone Therapy on the Bone Mineral Density of Women Treated with Thyroid Hormone Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approach |